Le Lézard
Classified in: Science and technology, Business
Subject: CCA

Instacart to Report Third Quarter 2024 Financial Results on November 12, 2024


SAN FRANCISCO , Oct. 15, 2024 /PRNewswire/ -- Instacart (NASDAQ: CART) today announced it will report its third quarter 2024 financial results after market close on Tuesday, November 12, 2024. The company's third quarter 2024 Shareholder Letter will be available on Instacart's Investor Relations website at https://investors.instacart.com.

Instacart management will also host a conference call to discuss the company's results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, November 12. To access a live webcast of the conference call, please visit the Investor Relations website at https://investors.instacart.com. After the call concludes, a replay will be made available on the Investor Relations website.

Instacart uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Instacart's Investor Relations website, press releases, SEC filings, public conference calls, and public webcasts, in addition to following Instacart's blog, which is located at www.instacart.com/company/blog.

About Instacart

Instacart, the leading grocery technology company in North America, works with grocers and retailers to transform how people shop. The company partners with more than 1,500 national, regional, and local retail banners to facilitate online shopping, delivery and pickup services from more than 85,000 stores across North America on the Instacart Marketplace. Instacart makes it possible for millions of people to get the groceries they need from the retailers they love, and for approximately 600,000 Instacart shoppers to earn by picking, packing and delivering orders on their own flexible schedule. The Instacart Platform offers retailers a suite of enterprise-grade technology products and services to power their e-commerce experiences, fulfill orders, digitize brick-and-mortar stores, provide advertising services, and glean insights. With Instacart Ads, thousands of CPG brands ? from category leaders to emerging brands ? partner with the company to connect directly with consumers online, right at the point of purchase. With Instacart Health, the company is providing tools to increase nutrition security, make healthy choices easier for consumers, and expand the role that food can play in improving health outcomes. For more information, visit www.instacart.com/company, and to start shopping, visit www.instacart.com. Maplebear Inc. is the registered corporate name of Instacart.

SOURCE Maplebear Inc. dba Instacart


These press releases may also interest you

9 nov 2024
LG Display, the world's leading innovator of display technologies, announced today its unveiling of the world's first Stretchable display capable of expanding up to 50%, the highest rate of elongation in the industry. At LG Science Park in Seoul on...

9 nov 2024
A report from Jiangxi International Communication Center (JXICC): Komurcu Busra, an international student from Nanchang University, talks about her life in China. She felt the simplicity of Chinese countryside and pure beauty of nature here....

9 nov 2024
A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, today shared progress of its Tmodtm CAR T-cell clinical programs...

9 nov 2024
As commercial energy rates continue to rise, businesses are feeling the pressure on their operating costs. Many companies are unknowingly overpaying for energy, despite better options available in deregulated markets. Bid On Energy, a leading...

9 nov 2024
CloudOne Digital, a leader in cloud-based infrastructure solutions, proudly announces the appointment of Zachary Smith to its Board of Directors. With a storied career including impactful roles at Packet and Equinix, Smith brings extensive expertise...

9 nov 2024
STARt-001 is the first clinical study to evaluate Marengo's novel, selective V? TCR agonist technology to promote in vivo expansion and reprogramming of tumor-infiltrating lymphocytes (TILs) in patients with advanced cancersInvikafusp alfa, a...



News published on and distributed by: